Deferred Tax Assets, Valuation Allowance of Hepion Pharmaceuticals, Inc. from 30 Jun 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Hepion Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2015 to 31 Dec 2025.
  • Hepion Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $45,489,265, a 2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $45,489,265 +$905,131 +2% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q4 2024 $44,584,134 +$39,497 +0.09% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q4 2023 $44,544,637 +$13,438,474 +43% 31 Dec 2023 10-K 08 Apr 2025 2024 FY
Q4 2022 $31,106,163 +$12,058,007 +63% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q4 2021 $19,048,156 +$8,809,119 +86% 31 Dec 2021 10-K 10 Apr 2023 2022 FY
Q4 2020 $10,239,037 +$2,528,006 +33% 31 Dec 2020 10-K 08 Apr 2022 2021 FY
Q4 2019 $7,711,031 -$11,766,869 -60% 31 Dec 2019 10-K 08 Apr 2022 2021 FY
Q4 2018 $19,477,900 +$3,438,200 +21% 31 Dec 2018 10-K 14 May 2020 2019 FY
Q4 2017 $16,039,700 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q2 2017 $20,962,100 +$6,537,400 +45% 30 Jun 2017 10-KT 26 Mar 2018 2017 FY
Q2 2016 $14,424,700 +$8,267,500 +134% 30 Jun 2016 10-KT 26 Mar 2018 2017 FY
Q2 2015 $6,157,200 30 Jun 2015 10-K 28 Sep 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.